Richard Furman, MD
25 years treating Acute Lymphocytic Leukemia
Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.
Weill Cornell Medical Center: 425 E 61st St 8th floor, New York, NY 10065, USA